Rigel Pharmaceuticals, Inc.

South San Francisco, Calif. – October 02, 2026 -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) has granted 35,275 restricted stock units to 18 non-executive employees under its Inducement Plan.

Rigel ties new hire equity to four-year vesting schedule

The restricted stock units vest over four years, with 25% of each grant releasing annually. The Compensation Committee of Rigel's Board of Directors approved the awards as an inducement material to new employees joining the company.

Grants comply with Nasdaq Listing Rule 5635(c)(4)

Rigel issued the awards in accordance with Nasdaq Listing Rule 5635(c)(4), which permits companies to grant equity inducements to new employees outside shareholder-approved equity plans. The rule requires public disclosure of such grants, which Rigel has now made.